aTYR PHARMA INC Debt Securities, Available-for-sale, Noncurrent
aTYR PHARMA INC (ATYR) had Debt Securities, Available-for-sale, Noncurrent of $4.00 million as of 2016-12-31, per its 10-K filed 2018-03-20.
Discontinued › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent · last filed 2018-03-20
- 2016-12-31: Debt Securities, Available-for-sale, Noncurrent $4.00M.
- 2016-09-30: Debt Securities, Available-for-sale, Noncurrent $10.33M.
- 2016-06-30: Debt Securities, Available-for-sale, Noncurrent $12.65M.
- 2015-12-31: Debt Securities, Available-for-sale, Noncurrent $29.81M.
| Period end | Debt Securities, Available-for-sale, Noncurrent |
|---|---|
| 2016-12-31 | $4.00M 10-K · filed 2018-03-20 |
| 2016-09-30 | $10.33M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $12.65M 10-Q · filed 2016-08-10 |
| 2015-12-31 | $29.81M 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |